NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update
March 31 2008 - 8:45AM
PR Newswire (US)
HUBBARD, Ohio, March 31 /PRNewswire-FirstCall/ -- NanoLogix, Inc.
(OTC:NNLXOTC:-OTC:News) a nano-biotechnology company is pleased to
provide the following updates on company events: NanoLogix
personnel are manning a booth and presenting at the National
Hydrogen Association Expo in Sacramento this week, with the company
being represented by William Hartman and Chris Novak. Mr. Hartman
will be presenting in the Exhibition Hall today, March 31, from
2:00-2:30 pm, on "Biohydrogen and Electricity Production from Waste
Water". Company CEO Bret Barnhizer was Marlene Bourne's guest on
The Bourne Report March 16, on the topic of Hydrogen Power. The
interview provides updates on hydrogen bioreactor operations.
Access: http://www.bournereport.com/radio.php Work on BNC and BNP
development for fast microorganism detection is proceeding at a
rapid pace, with a new patent application filed in March and
positive developments with both the Departments of Defense and
Homeland Security in late February. Director and Management
changes: Dr. Robert Ollar and John Chatterton have joined the Board
of Directors. Dr. Ollar is cofounder of NanoLogix (as Infectech),
the primary author of the majority of the company's granted
patents, and returns to the company after a six year hiatus. Mr.
Chatterton is former co-host of the History Channel series, Deep
Sea Detectives, and is one of the world's most accomplished and
well known underwater explorers. David Barnhizer has joined the
company as General Counsel, bringing to the company nearly forty
years of legal expertise. Detailed director and management team
information can be accessed at:
http://www.nanologixinc.com/index-2.html General Counsel David
Barnhizer stated: "NNLX is poised to make a significant move
forward under its new board of directors and management team headed
by CEO and Board Chairman Bret Barnhizer and complemented by a
reformed and greatly strengthened board of directors. A skilled and
knowledgeable team of professionals whose members are fully
dedicated to the advancement of NanoLogix has been put into place.
As NNLX General Counsel I am extremely pleased to be associated
with a group of professionals committed to the building of an
exceptional company whose patented technologies are on the cutting
edge of hydrogen energy extraction from industrial and commercial
wastes, as well as diagnostic tools that are drawing the attention
of governmental and commercial institutions." The company has
accepted the resignations of directors Hartman, Allan, and Cavallo
from all positions held. Mr. Hartman will continue to provide
business consulting services to NanoLogix. About NanoLogix, Inc.
NanoLogix is a leading innovator in the research, development, and
commercialization of nano-biotechnologies, applications and
processes. The Company has 31 granted Patents and multiple Patents
Pending for bioreactor- based Hydrogen Production, revolutionary
rapid medical testing technologies, and bioremediation. Information
on NanoLogix is available at http://www.nanologixinc.com/. This
press release contains statements, which may constitute "forward-
looking statements" within the meaning of the Securities Act of
1933 and the Securities Exchange Act of 1934, as amended by the
Private Securities Litigation Reform Act of 1995. Those statements
include statements regarding the intent, belief or current
expectations of NanoLogix, Inc., and members of its management as
well as the assumptions on which such statements are based.
Prospective investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve
risks and uncertainties, and that actual results may differ
materially from those contemplated by such forward-looking
statements. The Company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results. Contact: Investor Relations Bret Barnhizer, CEO
Telephone: 330-534-0800 E-mail: DATASOURCE: NanoLogix, Inc.
CONTACT: Investor Relations, Bret Barnhizer, CEO, NanoLogix, Inc.,
+1-330-534-0800, Web site: http://www.nanologixinc.com/
http://www.bournereport.com/radio.php
http://www.nanologixinc.com/index-2.html
Copyright